Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
7.00
+0.01 (0.14%)
At close: Oct 17, 2025, 4:00 PM EDT
6.61
-0.39 (-5.57%)
After-hours: Oct 17, 2025, 7:58 PM EDT
Kazia Therapeutics Market Cap
Kazia Therapeutics has a market cap or net worth of $7.83 million as of October 17, 2025. Its market cap has decreased by -39.06% in one year.
Market Cap
7.83M
Enterprise Value
6.02M
1-Year Change
-39.06%
Ranking
Category
Stock Price
$7.00
Market Cap Chart
Since September 1, 1999, Kazia Therapeutics's market cap has decreased from $141.44M to $7.83M, a decrease of -94.47%. That is a compound annual growth rate of -10.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 7.81M | 1.37% |
| Dec 31, 2024 | 7.71M | -33.47% |
| Dec 29, 2023 | 11.59M | 15.31% |
| Dec 30, 2022 | 10.05M | -90.96% |
| Dec 31, 2021 | 111.18M | 11.75% |
| Dec 31, 2020 | 99.49M | 217.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |